Post placeholder image
December 17, 2025 in Home Page, NanOlogy Press Release

NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio

Comments Off on NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio

PRESS RELEASENanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio FORT WORTH, Texas, ...

Read More
Post placeholder image
December 5, 2025 in Publications, Uncategorized

Therapeutic Advances in Medical Oncology: Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach

Comments Off on Therapeutic Advances in Medical Oncology: Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach

Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 18, ...

Read More
Post placeholder image
July 1, 2025 in Publications, Uncategorized

European Urology: A Systemic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer

Comments Off on European Urology: A Systemic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer

Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...

Read More
Post placeholder image
July 15, 2024 in Publications, Uncategorized

Journal of Thoracic Oncology: Phase 2a Intratumoral Large Surface Area Microparticle Paclitaxel in Stage 3/4 Lung Cancer

Comments Off on Journal of Thoracic Oncology: Phase 2a Intratumoral Large Surface Area Microparticle Paclitaxel in Stage 3/4 Lung Cancer

Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...

Read More
Post placeholder image
April 18, 2024 in Publications, Uncategorized

Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Comments Off on Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease April 1 ...

Read More
February 14, 2024 in Home Page, NanOlogy Press Release

NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs

Comments Off on NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs

NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs FORT WORTH (February 14, 2024) — NanOlogy LLC, a clinical-st ...

Read More
Post placeholder image
January 30, 2024 in Publications

Oncol Ther: Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies

Comments Off on Oncol Ther: Intratumoral Injection of Large Surface Area Microparticle Taxanes in Carcinomas Increases Immune Effector Cell Concentrations, Checkpoint Expression, and Synergy with Checkpoint Inhibitors: A Review of Preclinical and Clinical Studies
Read More
November 20, 2023 in NanOlogy Press Release

NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer

Comments Off on NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer

NanOlogy Announces an Abstract Has Been Accepted for Presentation at the IASLC North America Conference on Lung Cancer FORT WORTH (November 20, 2023) — NanOlogy LLC, a clinical-stage oncology ...

Read More